Fradlay Techem (Private) Limited.

Pakistan · Pharmaceuticals

Fradlay Techem Pvt Ltd has sourced 683 Metric Tons of Pharmaceutical Raw Material since its advent in Sep-2020. The yearly break is 26Mt 2020, 359Mt 2021, 298Mt 2022. It amounted in PKR Parity as 17.8 Million, 288 Million and 509 Million PKR. We are grateful for our Prestigious clients those who conferred confidence in us. Some of the prominent names to whom we have served are Searle, Pharmagen, Citi, Genix, Pacific, Unisa, Axis, Global, Rotex, Medisure, Ipram, Jawa, Mediate, CSH, Bryon, Vision, StarLabs, Evergreen, Selmore, Elko, Wnsfield, PPP, Opal, Genome, Epharm, Hamaz, English and others. This describes the spread and span of confidence. The number of supplies to the one leading client are 22. The single Largest consignment in terms of value amounted US$ 0.39 million the PKR Parity of which becomes 69 Million PKR. This describes the extent of customer's confidence. The product range we sourced encompasses APIs, Intermediates, Excipients and Solvents. The notable are Azithromycin, Clarithromycin, Ceftriaxone, Cefotaxime, Meropenem, Sitagliptin, Caffeine, Para Amino Phenol, Paracetamol, Ethyl Acetate, Mannitol, Voriconazole, IPA, MC, Voriconazole, Atorvastatin, Misoprostol, Tylosin, Gentamycin, Tilmicosin, Glimepiride, Montelukast, Alendronate, and others. The origins of our so far sourcing have been Italy, Taiwan, Cambodia, China, India. Nonetheless, The hardships had been the part of the going. The typical new venture constraints in different forms had been accompanying our Humble Start. The gradual evolution however is on to align itself in becoming of a Professional, Dependable and Well-Grounded option of raw material sourcing. SECP incorporation as Private Limited Company right from start and Being Responsible Taxpayer status to FBR are one of the same facet. The self-actualization is tried to get exercised by serving Beyond & More than just typical indenting. Once we are able to move forward in next phases we hope to In'sha'Allah progress equivalently.